Fulgent Historical Cash Flow

FLGT Stock  USD 20.24  0.11  0.55%   
Analysis of Fulgent Genetics cash flow over time is an excellent tool to project Fulgent Genetics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 4.6 M or Change In Working Capital of 3 M as it is a great indicator of Fulgent Genetics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Fulgent Genetics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fulgent Genetics is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

About Fulgent Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Fulgent balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Fulgent's non-liquid assets can be easily converted into cash.

Fulgent Genetics Cash Flow Chart

At this time, Fulgent Genetics' Change Receivables is comparatively stable compared to the past year. Cash And Cash Equivalents Changes is likely to gain to about 93.5 M in 2024, whereas Change In Cash is likely to drop slightly above 10.6 M in 2024.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Fulgent Genetics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Fulgent Genetics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Fulgent Genetics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Change Receivables is comparatively stable compared to the past year. Cash And Cash Equivalents Changes is likely to gain to about 93.5 M in 2024, whereas Change In Cash is likely to drop slightly above 10.6 M in 2024.

Fulgent Genetics cash flow statement Correlations

0.810.280.27-0.390.01-0.83-0.82-0.64-0.58-0.220.67-0.1-0.58-0.790.24-0.65-0.24-0.69-0.270.750.720.05
0.810.34-0.19-0.430.25-0.52-0.51-0.44-0.640.080.24-0.27-0.62-0.48-0.06-0.330.03-0.560.020.510.85-0.25
0.280.34-0.36-0.920.43-0.52-0.080.15-0.650.09-0.33-0.96-0.75-0.01-0.320.00.21-0.460.150.330.39-0.61
0.27-0.19-0.360.3-0.54-0.3-0.24-0.030.46-0.580.60.430.44-0.210.52-0.15-0.460.23-0.430.05-0.20.66
-0.39-0.43-0.920.3-0.110.660.280.060.580.220.170.90.840.21-0.030.190.150.540.2-0.57-0.470.32
0.010.250.43-0.54-0.110.120.160.13-0.650.92-0.32-0.35-0.280.16-0.950.170.94-0.280.89-0.20.27-0.96
-0.83-0.52-0.52-0.30.660.120.810.530.570.44-0.590.340.720.74-0.370.690.40.730.45-0.86-0.59-0.09
-0.82-0.51-0.08-0.240.280.160.810.920.520.31-0.86-0.140.590.99-0.450.960.430.840.49-0.93-0.62-0.25
-0.64-0.440.15-0.030.060.130.530.920.460.14-0.8-0.340.480.95-0.40.950.360.790.41-0.83-0.54-0.25
-0.58-0.64-0.650.460.58-0.650.570.520.46-0.43-0.150.480.870.50.410.48-0.370.86-0.31-0.58-0.690.66
-0.220.080.09-0.580.220.920.440.310.14-0.43-0.35-0.05-0.010.26-0.930.250.96-0.080.93-0.40.09-0.84
0.670.24-0.330.60.17-0.32-0.59-0.86-0.8-0.15-0.350.54-0.12-0.870.53-0.84-0.46-0.51-0.480.650.320.51
-0.1-0.27-0.960.430.9-0.350.34-0.14-0.340.48-0.050.540.63-0.210.31-0.22-0.190.24-0.16-0.16-0.270.58
-0.58-0.62-0.750.440.84-0.280.720.590.480.87-0.01-0.120.630.550.030.540.040.860.11-0.77-0.710.39
-0.79-0.48-0.01-0.210.210.160.740.990.950.50.26-0.87-0.210.55-0.440.970.420.830.47-0.91-0.58-0.26
0.24-0.06-0.320.52-0.03-0.95-0.37-0.45-0.40.41-0.930.530.310.03-0.44-0.45-0.99-0.02-0.970.49-0.040.93
-0.65-0.330.0-0.150.190.170.690.960.950.480.25-0.84-0.220.540.97-0.450.420.840.48-0.9-0.5-0.26
-0.240.030.21-0.460.150.940.40.430.36-0.370.96-0.46-0.190.040.42-0.990.420.040.97-0.510.02-0.88
-0.69-0.56-0.460.230.54-0.280.730.840.790.86-0.08-0.510.240.860.83-0.020.840.040.13-0.88-0.720.26
-0.270.020.15-0.430.20.890.450.490.41-0.310.93-0.48-0.160.110.47-0.970.480.970.13-0.57-0.09-0.83
0.750.510.330.05-0.57-0.2-0.86-0.93-0.83-0.58-0.40.65-0.16-0.77-0.910.49-0.9-0.51-0.88-0.570.630.18
0.720.850.39-0.2-0.470.27-0.59-0.62-0.54-0.690.090.32-0.27-0.71-0.58-0.04-0.50.02-0.72-0.090.63-0.27
0.05-0.25-0.610.660.32-0.96-0.09-0.25-0.250.66-0.840.510.580.39-0.260.93-0.26-0.880.26-0.830.18-0.27
Click cells to compare fundamentals

Fulgent Genetics Account Relationship Matchups

Fulgent Genetics cash flow statement Accounts

201920202021202220232024 (projected)
Sale Purchase Of Stock(21K)(62K)(4.2M)(76.1M)(27.8M)(26.4M)
Investments(27.9M)(289.9M)(460.9M)(261.3M)38.9M40.8M
Change In Cash5.2M75.5M77.5M(85.4M)18.0M10.6M
Free Cash Flow4.2M104.1M514.7M234.7M4.8M4.6M
Change In Working Capital(915K)(91.5M)(2.7M)2.0M2.8M3.0M
Begin Period Cash Flow6.7M12.0M87.4M164.9M79.5M40.4M
Total Cashflows From Investing Activities(29.0M)(326.4M)(546.5M)(261.3M)(235.2M)(223.4M)
Other Cashflows From Financing Activities38K104K96K31K(15.0M)(14.2M)
Depreciation2.1M3.0M11.0M32.7M31.8M33.3M
Other Non Cash Items1.5M8.0M16.0M43.5M109.7M115.2M
Capital Expenditures1.3M36.5M23.8M18.8M22.2M12.9M
Total Cash From Operating Activities5.5M140.6M538.6M253.5M27.0M25.7M
Change To Account Receivables(839K)(178.5M)42.3M68.6M2.4M2.5M
Change To Operating Activities229K11.1M19.8M(40.5M)(36.4M)(34.6M)
Net Income(411K)214.3M506.2M141.9M(167.8M)(159.4M)
Total Cash From Financing Activities28.8M261.3M85.4M(77.1M)(47.8M)(45.4M)
End Period Cash Flow12.0M87.4M164.9M79.5M97.5M50.9M
Other Cashflows From Investing Activities3.3M(27.9M)(1.4M)(81.8M)(73.7M)(70.0M)
Change To Netincome4.2M8.7M22.9M75.5M86.8M91.1M
Change To Liabilities(41K)108.6M(12.2M)(25.3M)(29.1M)(27.7M)
Stock Based Compensation3.2M8.2M15.9M32.6M42.9M45.1M
Change Receivables(2.0M)(839K)(178.5M)42.3M38.1M40.0M
Cash And Cash Equivalents Changes246K5.2M75.4M77.4M89.0M93.5M
Cash Flows Other Operating91K378K(16.3M)4.4M4.0M4.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.